Sirnaomics Ltd. (HKG:2257)
3.655
-0.135 (-3.56%)
Sep 21, 2026, 2:30 PM HKT
Sirnaomics Employees
Sirnaomics had 37 employees as of June 30, 2026. The number of employees did not change since the number was reported on December 31, 2025.
Employees
37
Change
n/a
Growth
n/a
Revenue / Employee
n/a
Profits / Employee
n/a
Market Cap
412.73M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Jun 30, 2026 | 37 | 0 | - | 37 | 0 |
| Dec 31, 2025 | 37 | -32 | -46.38% | 37 | 0 |
| Dec 31, 2024 | 69 | -76 | -52.41% | 69 | 0 |
| Dec 31, 2023 | 145 | -80 | -35.56% | 145 | 0 |
| Dec 31, 2022 | 225 | 50 | 28.57% | 222 | 3 |
| Dec 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Uni-Bio Science Group | 568 |
| JW (Cayman) Therapeutics Co. | 303 |
| Cutia Therapeutics | 268 |
| Immunotech Biopharm | 189 |
| 3D Medicines | 162 |
| Transcenta Holding | 150 |
| Kintor Pharmaceutical | 122 |
| Brii Biosciences | 80 |
Sirnaomics News
- 23 days ago - Sirnaomics Earnings release: H1 2026 - Filings
- 5 months ago - Sirnaomics Earnings release: H2 2025 - Filings
- 5 months ago - Sirnaomics Annual report: H2 2025 - Filings
- 1 year ago - Basal Cell Neoplasms Clinical Trial Pipeline Accelerates as 22+ Pharma Companies Rigorously Develop Drugs for Market Entry | DelveInsight - Benzinga